Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Human Genetics|May 29, 2003
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North AmericaJorge R Toro, Michael L Nickerson, Ming-Hui Wei, et al.Cancer Cell|September 3, 2002
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndromeMichael L Nickerson, Michelle B Warren, Jorge R Toro, et al.Journal of the American Academy of Dermatology|November 29, 2005
Defining early mycosis fungoidesNicola Pimpinelli, Elise A Olsen, Marco Santucci, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable changeSandra A Mitchell, David Jacobsohn, Kimberly E Thormann Powers, et al.Blood|December 31, 2009
Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasiaDonald C Vinh, Smita Y Patel, Gulbu Uzel, et al.The New England Journal of Medicine|September 21, 2007
STAT3 mutations in the hyper-IgE syndromeSteven M Holland, Frank R DeLeo, Houda Z Elloumi, et al.The New England Journal of Medicine|February 8, 2008
Phenotype and course of Hutchinson-Gilford progeria syndromeMelissa A Merideth, Leslie B Gordon, Sarah Clauss, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group reportSteven Z Pavletic, Paul Martin, Stephanie J Lee, et al.The New England Journal of Medicine|June 5, 2009
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonistIvona Aksentijevich, Seth L Masters, Polly J Ferguson, et al.The New England Journal of Medicine|August 11, 2006
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibitionRaphaela Goldbach-Mansky, Natalie J Dailey, Scott W Canna, et al.Pageof 4